GT MOLECULAR, INC.

Fort Collins, CO · Biotech · Private

Wastewater-based viral surveillance platform for monitoring influenza and SARS-CoV-2 genomic variants

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · gtmolecular.com

Sector: Biotech
Headquarters: Fort Collins, CO
Total capital: $1.8M

Federal grants: $513K; 2 awards · 2022; Rank in peer group#17 of 42
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $1.3M; 2 awards · Health and Human S; Rank in Biotech#163 of 4373
Granted patents: 0; 7 pending

Capital timeline

Latest events

Sep 2024Federal contractHealth and Human S · National Wastewater Surveillance System Multi-pathogen Assay Development, Optimization, Validation, And Support$1M
Sep 2022Federal contractHealth and Human S · Nwss Multi-assay Panel Development$297K
Feb 2022Federal grantHealth and Human S · Phase I · Improving influenza vaccines through wastewater-based macro-scale strain surveillance$257K
Jan 2022Federal grantHealth and Human S · Phase I · Improving influenza vaccines through wastewater-based macro-scale strain surveillance$257K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 42 peers

Line = median

Biotech · Platform

Federal grants#17 · top 40%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 7

Nov 6, 2025PendingSelective Blocking To Detect And Amplify Low Abundant TemplateUSPTOApplication 19199885
Aug 10, 2023PendingOff-target Blocking Sequences To Improve Target Discrimination By Polymerase Chain ReactionUSPTOApplication 18049563
PendingSelective Blocking To Detect And Amplify Low Abundant TemplateUSPTOApplication PCTUS2025027912

Show all 7 patent records

Selective Blocking To Detect And Amplify Low Abundant TemplateNov 6, 2025 · Application 19199885Pending
Off-target Blocking Sequences To Improve Target Discrimination By Polymerase Chain ReactionAug 10, 2023 · Application 18049563Pending
Selective Blocking To Detect And Amplify Low Abundant TemplateApplication PCTUS2025027912Pending
Off-target Blocking Sequences To Improve Target Discrimination By Polymerase Chain ReactionApplication PCTUS2022078666Pending
Multiplexed Genotyping Assays With A Single Probe Using Fluorescent Amplitude TuningApplication PCTUS2022020040Pending
Selective Blocking To Detect And Amplify Low Abundant TemplateApplication 63643014Pending
Selective Blocking To Detect And Amplify Low Abundant TemplateApplication 63659266Pending

GLYCOSCIENTIFIC, L.L.C.Similar federal contract value in Biotech · $1.4M in contracts
GENEINFOSEC INCSimilar federal contract value in Biotech · $1.4M in contracts
BIOO SCIENTIFIC CORPORATIONSimilar federal contract value in Biotech · $1.4M in contracts
GELSANA THERAPEUTICS INCSimilar federal contract value in Biotech · $1.3M in contracts
Schrodinger, Inc.Similar federal contract value in Biotech · $1.3M in contracts
OMICRON BIOCHEMICALS, INC.Similar federal contract value in Biotech · $1.3M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.